Sudha K. Iyengar, Jeffrey R. Schelling, John R. Sedor 

Slides:



Advertisements
Similar presentations
Renal disease and hypertension in non–insulin-dependent diabetes mellitus Nuhad Ismail, Bryan Becker, Piotr Strzelczyk, Eberhard Ritz Kidney International.
Advertisements

Epidemiology of end-stage renal disease: International comparisons of renal replacement therapy Francesco Paolo Schena Kidney International Volume 57,
Chapter 1: Definition and classification of CKD Kidney International Supplements Volume 3, Issue 1, Pages (January 2013) DOI: /kisup
Stephen P. McDonald, Graeme R. Russ  Kidney International 
Plasma sodium and hypertension
MariLia Bahiense Oliveira, Joao Egidio Romao, Roberto Zatz 
Volume 83, Issue 3, Pages (March 2013)
Lipopheresis in the nephrotic syndrome
Epidemiology of diabetic nephropathy in Spain
End-stage renal disease prevention strategies in Latin America
Volume 58, Issue 4, Pages (October 2000)
Volume 86, Issue 6, Pages (December 2014)
Volume 68, Pages S52-S56 (December 2005)
Progression of renal failure and hypertensive nephrosclerosis
Mortality caused by sepsis in patients with end-stage renal disease compared with the general population  Mark J. Sarnak, Bertrand L. Jaber  Kidney International 
Volume 77, Issue 1, Pages 6-8 (January 2010)
Francesco Paolo Schena  Kidney International 
Volume 66, Issue 3, Pages (September 2004)
Anemia as a risk factor for chronic kidney disease
Comorbidity and confounding in end-stage renal disease
Enlarged nephrons and severe nondiabetic nephropathy in hepatocyte nuclear factor-1β (HNF-1β) mutation carriers  Jørn V. Sagen, Leif Bostad, Pål R. Njølstad,
Survival advantage in Asian American end-stage renal disease patients1
Volume 70, Issue 11, Pages (December 2006)
Renal risk scores: Progress and prospects
Volume 86, Issue 2, Pages (August 2014)
The epidemiology of chronic kidney disease
The role of protein kinase C activation in diabetic nephropathy
Study of Heart and Renal Protection (SHARP)
Acute myocardial infarction in patients with end-stage renal disease
Volume 70, Issue 12, Pages (December 2006)
Volume 67, Pages S48-S51 (January 2005)
Fructose intake as a risk factor for kidney stone disease
Volume 87, Issue 1, Pages (January 2015)
New insights in uremic toxins
Volume 81, Issue 6, Pages (March 2012)
The third World Kidney Day: Looking back and thinking forward
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 63, Pages S38-S42 (February 2003)
Proteinuria and hypertensive nephrosclerosis in African Americans
Microbiology and outcomes of peritonitis in North America
Nephrology in Latin America, with special emphasis on Brazil
AGEs in foods: Do they play a role in uremia?
Volume 93, Issue 1, Pages (January 2018)
Atrial fibrillation in end-stage renal disease: an emerging problem
The global challenge of chronic kidney disease
V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen 
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Transforming growth factor beta and progression of renal disease
Circadian regulation of renal function
Homocysteine, renal function, and risk of cardiovascular disease
E.A. Friedman, A.L. Friedman, P. Eggers  Kidney International 
Stephen P. McDonald, Graeme R. Russ  Kidney International 
ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: The African American Study of Kidney Disease and Hypertension (AASK) trial 
Volume 74, Issue 9, Pages (November 2008)
Peritoneal dialysis in Mexico
Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program  Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William.
Clinical benefits of slowing the progression of renal failure
Volume 70, Pages S84-S90 (November 2006)
Atherosclerotic nephropathy
Volume 55, Pages S3-S16 (June 1999)
Charles A. Herzog  Kidney International 
Renal replacement therapy in Latin America
H.J. Chin, H. Ro, H.J. Lee, K.Y. Na, D.-W. Chae  Kidney International 
T cells and T-cell receptors in acute renal failure
Volume 54, Pages S112-S119 (December 1998)
Morphology of the heart and arteries in renal failure
Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease?  Danilo Fliser, Jan T. Kielstein, Hermann Haller, Stefanie M. Bode-Böger  Kidney.
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Presentation transcript:

Approaches to understanding susceptibility to nephropathy: From genetics to genomics  Sudha K. Iyengar, Jeffrey R. Schelling, John R. Sedor  Kidney International  Volume 61, Issue 1, Pages S61-S67 (January 2002) DOI: 10.1046/j.1523-1755.2002.0610s1061.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 A comparison of HCFA 2728 diagnostic categories demonstrated significant differences between CAs and AAs. Hypertensive nephrosclerosis was more common cause of ESRD among AAs, whereas type 2 diabetes was equally frequent in the two ethnic groups. Kidney International 2002 61, S61-S67DOI: (10.1046/j.1523-1755.2002.0610s1061.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 Data from the ESRD genetics project demonstrating that aggregation of family history among AAs is greater than among CAs. We observed that independent of race females demonstrated greater familial clustering. Kidney International 2002 61, S61-S67DOI: (10.1046/j.1523-1755.2002.0610s1061.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 3 Twenty-five SAGE tags demonstrated differential expression patterns between the ROP-Os/+ and C57-Os/+ renal libraries. Each bar on the x axis corresponds to a tag, whereas the units on the y axis represent that tag frequency. Twelve tags are overexpressed, and thirteen tags are underexpressed in the ROP-Os/+ library. Kidney International 2002 61, S61-S67DOI: (10.1046/j.1523-1755.2002.0610s1061.x) Copyright © 2002 International Society of Nephrology Terms and Conditions